You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
FORBES LIFE<br />
The Second<br />
Time Around<br />
When watch collector Pascal<br />
Raffy bought the venerable<br />
Swiss brand Bovet, he reinvented<br />
the company—and himself.<br />
BY ROBERTA NAAS<br />
By the age of 36, Pascal Raffy, a French<br />
pharmaceutical executive, was enjoying<br />
early retirement, spending time<br />
with his family and keeping an eye out<br />
for new investments. Knowing Raffy was a passionate<br />
watch collector, with hundreds of vintage<br />
timepieces, an investment banker friend would<br />
often tempt him with opportunities in the watch<br />
world. Each time, Raffy would decline—until one<br />
day his friend insisted Raffy do a blind touch test<br />
with a timepiece.<br />
“My friend put it, with several of my other<br />
watches, under a cloth,” Raffy recalls. “One by<br />
one, I felt those watches, and when my hand fell<br />
on one of them, I knew it was truly different. I felt<br />
the crown at the top of the strap and realized this<br />
was a watch with its own identity. Then I looked<br />
at it, and in a nanosecond it talked to me. I took<br />
my loupe and saw that it was a beautiful piece of<br />
horology. It had substance. I was interested.”<br />
And he had the means to make a significant<br />
investment. At 25, Raffy bought into a family-run<br />
French pharmaceuticals company, where, after a<br />
merger, he became head of the firm Synthélabo.<br />
After several successful years in France, Raffy expanded<br />
Synthélabo into North Africa, where he<br />
not only began the production of drugs but also<br />
built dedicated facilities for marketing and distributing<br />
them to doctors on the continent.<br />
During the ten years Raffy led Synthélabo, he<br />
turned it into the third-largest pharmaceutical<br />
group in France. But after his young daughter lamented<br />
that he worked too much, he decided to<br />
cash out. It took 18 months to organize the sale<br />
of Synthélabo to Sanofi, but Raffy wanted to leave<br />
the company in good hands. “Whenever you start<br />
something in an area of health and caring for<br />
human beings—where there is also a moral dimension<br />
in addition to the business side—it is<br />
very difficult to stop work,” he says.<br />
The retirement was short-lived once Raffy<br />
touched that watch under the cloth. The timepiece<br />
was made by Bovet. Swiss watchmaker Edouard<br />
Bovet had founded the brand in England<br />
in 1822, when the Silk Road was flourishing<br />
and there was demand in Asia for fine handmade<br />
pocket watches. Bovet’s earliest watches<br />
were hand-painted and created in identical pairs<br />
so if one watch needed to return to Europe for repair,<br />
the owner still had a fine watch to wear. The<br />
business operated out of England, but the watches<br />
were made in Fleurier, Switzerland, where they<br />
continued to be produced until the late 1930s.<br />
By 2000, when Raffy learned that Bovet was<br />
looking for a new investor, the two men who<br />
The art of time: “You<br />
should be able to<br />
take a loupe and<br />
know it is a Bovet,<br />
no matter the price,”<br />
says Raffy, wearing<br />
one of his Amadeo<br />
watches, which easily<br />
converts to a pocket<br />
watch or table clock<br />
(at right).<br />
PHOTOGRAPHS BY JAMEL TOPPIN FOR FORBES<br />
106 | FORBES JUNE <strong>13</strong>, <strong>2017</strong>